// STATE LEGISLATION TRACKER

Florida SB 632: Treatment of Chronic and Terminal Illnesses

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Florida
Bill: SB 632
Session: 2026
Filed: 2025-02-11
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Florida SB632 dealt with automobile insurance requirements for transportation network companies, drivers, and vehicle owners. Based on the title, subject, and status, it has no apparent connection to compounded peptides, prescribing, telehealth care, clinician scope, FDA compounding rules, controlled substances, or prescription monitoring.

Key Points

No apparent effect on peptide prescribing or access
Does not appear to address compounding pharmacies
Does not appear to change telehealth rules
No apparent impact on NP or naturopathic scope
No apparent controlled-substance or PDMP changes

What to Watch For

Note This bill appears limited to rideshare-related automobile insurance rules.

Note Because it died in committee, it is not moving forward in the 2026 session.

Where the Bill Stands

The bill died in the Senate Transportation committee on March 13, 2026.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws